Yu-ting Dai

State Key Laboratory Of Medical Genomics
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML.

A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML.

Journal: Journal of translational medicine
Published: March 31, 2025

Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.

Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2025

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging.

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging.

Journal: Blood
Published: November 15, 2024

TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC.

TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC.

Journal: Cell & bioscience
Published: October 03, 2024

Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures.

Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures.

Journal: Frontiers in immunology
Published: April 28, 2024

Aging and comprehensive molecular profiling in acute myeloid leukemia.

Aging and comprehensive molecular profiling in acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 29, 2024

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.

Journal: Signal transduction and targeted therapy
Published: September 27, 2023

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.

Journal: Science bulletin
Published: June 19, 2023

Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level.

Case Report: Molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level.

Journal: Frontiers in immunology
Published: April 23, 2023

Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.

Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.

Journal: Acta pharmacologica Sinica
Published: April 17, 2023

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 28, 2022

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 06, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026